AU Patent

AU2013371074B2 — Eicosapentaenoic acid (EPA) formulations

Assigned to Qualitas Health Inc · Expires 2018-07-26 · 8y expired

What this patent protects

Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

USPTO Abstract

Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013371074B2
Jurisdiction
AU
Classification
—
Expires
2018-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Qualitas Health Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.